Published on in Vol 7 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/47486, first published
.
Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies
Toward Personalized Medicine Approaches for Parkinson Disease Using Digital Technologies
1 Neuroscience Global Drug Development, Novartis Pharma AG, Basel, Switzerland
2 GDD Connected Health and Innovation Group, Novartis Pharmaceuticals, East Hanover, NJ, United States
3 Clinical and Translational Science Institute, Tufts University Medical Center, Boston, MA, United States